Press Releases

Researchers have identified uric acid as a potential therapy to enhance recovery from acute ischemic stroke using a new method for conducting preclinical animal research.

Using a novel deep brain stimulation (DBS) device capable of recording brain signals, researchers have identified a pattern of brain activity or “biomarker” related to clinical signs of recovery from treatment-resistant depression.

Study examined athletes who played contact sports, showed CTE symptoms, and died before age 30.

Early NIH-funded trial is first step towards development of a potential stroke treatment

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, released a new strategic plan to identify research opportunities that may help eliminate health disparities and inequities in neurological disorders.

NIH-supported trial first step in developing new approach to treat myasthenia gravis

NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment.

For the first time, researchers have recorded pain-related data from inside the brain of individuals with chronic pain disorders caused by stroke or amputation (phantom limb pain).

Among people who have had COVID-19, adults with obstructive sleep apnea were more likely to experience long-term symptoms suggestive of long COVID than those without the sleep disorder, according to a large study supported by the National Institutes of Health (NIH).

Scientists at the National Institutes of Health have identified new genetic risk factors for two types of non-Alzheimer’s dementia.